Am J Respir Crit Care Med 203(7):831840 Albogami Y, Cusi K, Daniels MJ, Wei YJ, Winterstein AG (2021) Glucagon-Like peptide 1 receptor agonists and chronic lower respiratory disease exacerbations among patients with type 2 diabetes
Apr 28th, 2026 How SEMAX supports Brain Function and Cognitive Performance Semax is a neuroactive peptide with early evidence suggesting potential cognitive and neuroprotective benefits, but its clinical use remains limited by insufficient large-scale human data, regulatory restrictions, and an uncertain safety profile
Acne: Types, Causes, Treatment, and Prevention 2
Indication expansion, such as approvals for additional metabolic and cardiovascular conditions, is broadening patient access and driving adoption
Side effects are rare but may include mild digestive discomfort or allergic reactions